Lloyds Engineering Works Fund Raise of ₹987.2 Cr

Lloyds Engineering Works Board Meeting Date

Lloyds Engineering Works schedules a 2 November 2026 board meeting to review unaudited standalone and consolidated results for September 2026. Trading window closed from 1 October.

Lloyds Engineering Works Other Announcement

Lloyds Engineering Works Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.

Lloyds Engineering Works Acquisition

Lloyds Engineering Works Ltd held a court-convened shareholder meeting to approve the Scheme of Merger by absorption of three transferor companies. Voting results will be announced separately.

Lloyds Engineering Works Merger & Restructuring

Lloyds Engineering Works held a court-convened meeting to seek shareholder approval for the proposed merger by absorption of three transferor companies into the entity.

Lloyds Engineering Works Share Pledge

Lloyds Enterprises Limited created a pledge on 1.10 crore equity shares of Lloyds Engineering Works Limited in favour of Aditya Birla Capital Limited.

Lloyds Engineering Works Employee Stock Options

Lloyds Engineering Works granted 22,52,050 employee stock options to eligible employees of the company and its subsidiary under the ESOP 2021 plan at ₹9.50 per option.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr